Characteristics | Control | Ketorolac | Parecoxib | P |
---|---|---|---|---|
Number | 32 | 32 | 32 | Â |
Sex | Â | Â | Â | 0.575 |
Male | 13 (40.6) | 9 (28.1) | 11 (34.4) | Â |
Female | 19 (59.4) | 23 (71.9) | 21 (65.6) | Â |
Age (yr)* | 55.6 ± 14 | 58.2 ± 9.5 | 58 ± 8.6 | 0.582 |
Weight (kg)* | 66.5 ± 11 | 65.6 ± 12.2 | 64.3 ± 13.1 | 0.76 |
Height (cm)* | 160.2 ± 8.1 | 159.5 ± 7.9 | 158.8 ± 7.7 | 0.776 |
BMI* | 26 ± 4.8 | 26.4 ± 3.2 | 26 ± 3.6 | 0.913 |
ASA status | Â | Â | Â | 0.715 |
I | 10 (31.25) | 9 (28.13) | 11 (34.37) | Â |
II | 22 (68.75) | 23 (71.87) | 21 (65.63) | Â |
Number fusion levels | Â | Â | Â | 0.703 |
I | 10 (31.2) | 15 (46.9) | 11 (34.4) | Â |
II | 15 (46.9) | 13 (40.6) | 15 (46.9) | Â |
III | 7 (21.9) | 4 (12.5) | 6 (18.8) | Â |
Duration of surgery (min)* | 165.7 ± 46.7 | 157 ± 33.3 | 189.2 ± 49.3 | 0.069 |
Estimated blood loss (mL) | 450 (328.5) | 489 (316.3) | 587.5 (361.2) | 0.246 |
Intraoperative fentanyl | 162.6 (37.5) | 157.4 (43.8) | 175.9 (37.5) | 0.121 |